LFWDNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Lifeward Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$5.93−0.07 (-1.17%)
Close on Oct 19, 2026
- Market cap
- $16.58M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Lifeward's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Lind Global Fund II LP | 945,746 | 8.90% | 13G (passive) | Jan 6, 2025 |
| Oramed Pharmaceuticals Inc. | 1,528,221 | 49.90% | 13D (active) | Mar 25, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| William Mark Grant | President & CEO, Director | – | – | Mar 27, 2026 |
| Lawrence J. Jasinski | Chief Executive Officer, Director | 100,870 | 3.56% | May 22, 2025 |
| Keith Dale Rose | Chief Medical Officer | 17,083 | 0.60% | May 20, 2026 |
| Almog Adar | Chief Financial Officer | 262,500 | 9.27% | Mar 27, 2026 |
| Jeannine Lynch | VP of Market Access & Strategy | 142,134 | 5.02% | Dec 12, 2025 |
| Haggai Zamir | Director | 6,711 | 0.24% | Sep 10, 2026 |
| Yonason Greenwald | Director | 6,711 | 0.24% | Aug 28, 2026 |
| Avraham Gabay | Director | 13,643 | 0.48% | Aug 24, 2026 |
| Moshe H. Rozenbaum | Director | 11,485 | 0.41% | Apr 13, 2026 |
| William Mark Sigsbee | Director | 11,485 | 0.41% | Apr 13, 2026 |
| Nadav Kidron | Director | 7,657 | 0.27% | Mar 27, 2026 |
| Miriam Kidron | Director | 7,657 | 0.27% | Mar 27, 2026 |
| Yehuda Reznick | Director | 7,657 | 0.27% | Mar 27, 2026 |
| Hadar Levy | Director | 51,576 | 1.82% | Aug 7, 2025 |
| Michael Swinford | Director | 100,960 | 3.56% | Aug 7, 2025 |
| John William Poduska Sr | Director | 55,953 | 1.98% | Aug 7, 2025 |
| Robert J. Marshall Jr. | Director | 35,920 | 1.27% | Aug 7, 2025 |
| Joseph E. Turk Jr | Director | 104,973 | 3.71% | Aug 7, 2025 |
| Randel Richner | Director | 57,487 | 2.03% | Aug 7, 2025 |
| Joshua Hexter | – | – | – | Sep 1, 2026 |
| Pharmaceuticals Inc. Oramed | 10% owner | 1,250,363 | 44.15% | May 14, 2026 |
| Global Fund II LP Lind | 10% owner | 10,875,741 | 384.03% | Jan 8, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Avraham Gabay Director | Aug 20, 2026 | Award | +13,643 | – | – | 13,643 |
| Haggai Zamir Director | Aug 14, 2026 | Award | +6,711 | – | – | 6,711 |
| Yonason Greenwald Director | Aug 14, 2026 | Award | +6,711 | – | – | 6,711 |
| Keith Dale Rose Chief Medical Officer | May 1, 2026 | Award | +15,000 | – | – | 17,083 |
| Moshe H. Rozenbaum Director | Mar 25, 2026 | Award | +11,485 | – | – | 11,485 |
| William Mark Sigsbee Director | Mar 25, 2026 | Award | +11,485 | – | – | 11,485 |
| Miriam Kidron Director | Mar 25, 2026 | Award | +7,657 | – | – | 7,657 |
| Yehuda Reznick Director | Mar 25, 2026 | Award | +7,657 | – | – | 7,657 |
| Nadav Kidron Director | Mar 25, 2026 | Award | +7,657 | – | – | 7,657 |
| Jeannine Lynch VP of Market Access & Strategy | Dec 11, 2025 | Award | +50,000 | – | – | 96,067 |
| Jeannine Lynch VP of Market Access & Strategy | Sep 2, 2025 | Sale | −1,591 | $0.64 | $1.02K | 46,067 |
| Joseph E. Turk Jr Director | Aug 1, 2025 | Award | +71,839 | – | – | 86,457 |
| Robert J. Marshall Jr. Director | Aug 1, 2025 | Award | +35,920 | – | – | 35,920 |
| John William Poduska Sr Director | Aug 1, 2025 | Award | +35,920 | – | – | 55,953 |
| Michael Swinford Director | Aug 1, 2025 | Award | +35,920 | – | – | 45,960 |
| Hadar Levy Director | Aug 1, 2025 | Award | +35,920 | – | – | 51,576 |
| Randel Richner Director | Aug 1, 2025 | Award | +35,920 | – | – | 57,487 |
| Lawrence J. Jasinski Chief Executive Officer, Director | May 21, 2025 | Sale | −1,909 | $1.26 | $2.41K | 98,728 |
| Global Fund II LP Lind 10% owner | Jan 7, 2025 | Sale | −700 | $2.69 | $1.88K | 857,996 |
| Global Fund II LP Lind 10% owner | Jan 7, 2025 | Sale | −190,734 | $1.94 | $370.02K | 858,696 |
| Global Fund II LP Lind 10% owner | Jan 6, 2025 | Sale | −298,350 | $3.46 | $1.03M | 1,049,430 |
| Global Fund II LP Lind 10% owner | Jan 6, 2025 | Sale | −83,326 | $3.01 | $250.81K | 1,347,780 |
| Randel Richner Director | Dec 13, 2024 | Sale | −4,285 | $1.68 | $7.20K | 0 |
| Joseph E. Turk Jr Director | Dec 13, 2024 | Buy | +6,000 | $1.69 | $10.14K | 18,516 |
| Michael Swinford Director | Nov 25, 2024 | Buy | +21,622 | $2.03 | $43.89K | 65,040 |
| Michael Swinford Director | Nov 22, 2024 | Buy | +16,907 | $1.83 | $30.94K | 43,418 |
| Michael Swinford Director | Nov 20, 2024 | Buy | +16,471 | $1.84 | $30.31K | 26,511 |
| Lawrence J. Jasinski Chief Executive Officer, Director | Sep 13, 2024 | Sale | −2,672 | $3.26 | $8.71K | 100,637 |
| Jeannine Lynch VP of Market Access & Strategy | Sep 3, 2024 | Sale(10b5-1 plan) | −1,625 | $3.30 | $5.36K | 47,658 |
| Jeannine Lynch VP of Market Access & Strategy | Aug 2, 2024 | Sale(10b5-1 plan) | −1,783 | $3.84 | $6.85K | 49,283 |
| Lawrence J. Jasinski Chief Executive Officer, Director | Aug 2, 2024 | Sale | −2,665 | $3.84 | $10.23K | 103,309 |
| Jeannine Lynch VP of Market Access & Strategy | Jul 1, 2024 | Sale(10b5-1 plan) | −1,834 | $3.83 | $7.02K | 51,066 |
| Lawrence J. Jasinski Chief Executive Officer, Director | Jun 18, 2024 | Sale | −3,466 | $4.22 | $14.63K | 105,974 |
| Michael A. Lawless Chief Financial Officer | May 23, 2024 | Buy | +2,000 | $4.97 | $9.94K | 4,150 |
| Joseph E. Turk Jr Director | May 23, 2024 | Buy | +7,916 | $5.01 | $39.66K | 12,516 |
| Joseph E. Turk Jr Director | May 22, 2024 | Buy | +84 | $5.01 | $421 | 4,600 |
| Lawrence J. Jasinski Chief Executive Officer, Director | May 21, 2024 | Sale | −1,620 | $4.91 | $7.95K | 109,440 |
| Michael Swinford Director | Apr 18, 2024 | Award | +10,040 | – | – | 10,040 |
| Global Fund II LP Lind 10% owner | Nov 20, 2023 | Buy | +12,000 | $0.73 | $8.76K | 10,017,745 |
| Global Fund II LP Lind 10% owner | Nov 17, 2023 | Buy | +42,917 | $0.73 | $31.33K | 10,005,745 |
| Global Fund II LP Lind 10% owner | Nov 14, 2023 | Buy | +72,818 | $0.68 | $49.52K | 9,962,828 |
| Global Fund II LP Lind 10% owner | Sep 26, 2023 | Sale(10b5-1 plan) | −5,031,200 | $0.70 | $3.52M | 0 |
| Global Fund II LP Lind 10% owner | Sep 26, 2023 | Buy | +5,031,200 | $0.70 | $3.52M | 9,890,010 |
| John William Poduska Sr Director | Sep 13, 2023 | Award | +59,595 | – | – | 140,240 |
| Randel Richner Director | Sep 13, 2023 | Award | +59,595 | – | – | 150,980 |
| Jeff Dykan Director | Sep 13, 2023 | Award | +59,595 | – | – | 119,157 |
| Hadar Levy Director | Sep 13, 2023 | Award | +59,595 | – | – | 109,595 |
| Lawrence J. Jasinski Chief Executive Officer, Director | Sep 13, 2023 | Award | +200,000 | – | – | 751,276 |
| Joseph E. Turk Jr Director | Sep 13, 2023 | Award | +59,595 | – | – | 102,330 |
| Joseph E. Turk Jr Director | Sep 7, 2023 | Buy | +27,309 | $0.68 | $18.57K | 31,616 |
| Joseph E. Turk Jr Director | Sep 6, 2023 | Buy | +30 | $0.68 | $20 | 4,307 |
| Global Fund II LP Lind 10% owner | Sep 6, 2023 | Buy | +161 | $0.69 | $111 | 4,858,810 |
| Global Fund II LP Lind 10% owner | Sep 5, 2023 | Buy | +19,779 | $0.70 | $13.85K | 4,858,649 |
| Global Fund II LP Lind 10% owner | Sep 1, 2023 | Buy | +11,597 | $0.71 | $8.23K | 4,838,870 |
| Joseph E. Turk Jr Director | Sep 1, 2023 | Buy | +2,661 | $0.68 | $1.81K | 4,277 |
| Jeannine Lynch VP of Market Access & Strategy | Aug 31, 2023 | Sale(10b5-1 plan) | −9,529 | $0.69 | $6.58K | 370,303 |
| Joseph E. Turk Jr Director | Aug 29, 2023 | Buy | +1,616 | $0.62 | $1.00K | 1,616 |
| Global Fund II LP Lind 10% owner | Aug 28, 2023 | Buy | +9,125 | $0.64 | $5.84K | 4,827,273 |
| Global Fund II LP Lind 10% owner | Aug 25, 2023 | Buy | +16,020 | $0.62 | $9.93K | 4,818,148 |
| Michael A. Lawless Chief Financial Officer | Aug 25, 2023 | Buy | +5,000 | $0.62 | $3.10K | 15,051 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Lawrence J. Jasinski Officer | Sep 16, 2024 | 2,672 | $8.74K | Sep 13, 2024 | Restricted Stock Units |
| Lawrence J. Jasinski Officer | Aug 5, 2024 | 2,665 | $11.78K | Aug 2, 2024 | Restricted Stock Units |
| Lawrence J. Jasinski Officer | Jun 20, 2024 | 3,466 | $15.15K | Jun 18, 2024 | Restricted Stock Units |
| Yasushi Ichiki Director | Nov 20, 2023 | 15,607 | $11.83K | Nov 17, 2023 | Restricted stock unit |
| Yasushi Ichiki Director | Nov 17, 2023 | 15,038 | $10.98K | Nov 16, 2023 | Restricted stock unit |
| Aryeh Dan Director | Sep 18, 2023 | 2,515 | $2.14K | Sep 15, 2023 | Restricted stock unit |
| Aryeh Dan Director | Aug 23, 2023 | 9,582 | $6.49K | Aug 15, 2023 | RSU |
| Lawrence J. Jasinski Officer | Aug 3, 2023 | 15,237 | $11.05K | Aug 2, 2023 | Restricted Stock Units |
| Lawrence J. Jasinski Officer | Jun 21, 2023 | 22,920 | $13.87K | Jun 20, 2023 | RSU |